During the past decade, Policlinica de Diagnostic Rapid conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Policlinica de Diagnostic Rapid" #1 sponsor was "Amgen" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Novacea" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinica de Diagnostic Rapid" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Policlinica de Diagnostic Rapid" are "Anaplastic Large-cell Lymphoma" (1 trials), "Chemotherapy-induced Thrombocytopenia" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "First Line Non-Small Cell Lung Cancer" (1 trials) and "Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Policlinica de Diagnostic Rapid" in a lesser frequency.

Most popular intervention types in "Policlinica de Diagnostic Rapid" are "Drug" (8 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (2 trials), "Cyclophosphamide" (2 trials), "Placebo" (2 trials), "Rituximab" (2 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinica de Diagnostic Rapid" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Policlinica de Diagnostic Rapid". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Policlinica de Diagnostic Rapid, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Policlinica de Diagnostic Rapid, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".